Saturday, November 27, 2021

NEWS

WHO Approves Emergency Use of Moderna Covid-19 Vaccine

WHO Approves Emergency Use of Moderna Covid-19 Vaccine

Geneva, May 1 (Prensa Latina) The World Health Organization (WHO) approved the emergency use of the Covid-19 vaccine from American laboratories Moderna, the global health entity reported today in a statement.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Based on messenger RNA and with an efficacy of 94.1 percent, the injectable was thus linked to the AstraZeneca, Pfizer-BioNTech and Johnson & Johnson vaccines to the WHO lists for application.

In this way, the statement explains, countries are allowed to accelerate their own regulatory approval to import and administer the immunogens.

The WHO said similar approvals for the vaccines will also arrive from Chinese laboratories Sinopharm and Sinovac in the coming days and weeks.

Reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), the vaccine is recommended for people over 18 years of age.

Although provided as a frozen suspension at minus 25 to 15 degrees Celsius in a multidose bulb, the vials can be stored refrigerated at two to eight degrees Celsius for up to 30 days prior to applying the first dose.

This means that ‘cold chain equipment may not always be needed to implement the vaccine,’ the developers explain.

ef/ga/alb

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.